Collaborate Forward Playbook

Accelerate: Remarkable Study Startup

A private, facilitated working session that puts your startup process in front of eight credentialed clinical research site leaders — selected and curated by SCRS, not by you.

The Lab Question

What happens between site selection and first patient screened — and what sponsor and CRO behaviors in that window most accelerate or delay site activation?

8 site leaders

Credentialed SCRS member-site faculty in your private cohort

3 meetings

Community session, private working session, outcomes design

5 questions

Your organization-specific priorities steer the panel

Co-branded summary

SCRS-authored insights, recommended actions, and outcome goals

Startup is the most controllable variable in your timeline

Delays between site selection and first patient screened are rarely caused by sites alone. They are caused by decisions upstream — and most of those decisions belong to sponsors and CROs.

Most organizations know startup is broken. Few have a structured way to hear from sites exactly which of their own decisions are making it worse.

WHERE ACTIVATION ACTUALLY STALLS

Information gaps: feasibility packages that leave sites guessing at what the protocol will actually demand.
Budget and contract friction: negotiation cycles that add weeks before a single patient is screened.
System access failures: credentials, training, and portal access that arrive after the site is ready to work.
Communication breakdowns: unclear ownership between sponsor, CRO, and site during the handoff window.